Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions

Antiviral Research

Volumn 99, Issue 3, 2013, Pages 318-327

  Palù, Giorgio ^a   Loregian, Arianna ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antiviral therapy; Herpesvirus; Influenza virus; Protein protein interaction; Viral polymerase

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; DICLAZURIL; DNA POLYMERASE; FOSCARNET; GANCICLOVIR; NSC 373989; RNA POLYMERASE; SIALIDASE INHIBITOR; TRENBOLONE ACETATE; UNCLASSIFIED DRUG; VALACICLOVIR; VALGANCICLOVIR; VIRUS PROTEIN; DNA DIRECTED RNA POLYMERASE; PROTEIN BINDING; PROTEIN SUBUNIT; ADAMANTANE; HOMODIMER; INFLUENZA VACCINE; MONOMER; OSELTAMIVIR; VIRAL POLYMERASE;

ANTIVIRAL ACTIVITY; COMPETITIVE INHIBITION; CRYSTAL STRUCTURE; CYTOTOXICITY; DIMERIZATION; DNA BINDING; DNA REPLICATION; ENZYME ACTIVE SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBUNIT; FLUORESCENCE POLARIZATION; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HOST CELL; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HYDROGEN BOND; IN VITRO STUDY; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; REVIEW; STRUCTURE ACTIVITY RELATION; VIRUS ENTRY; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; INFLUENZA, HUMAN; METABOLISM; ORTHOMYXOVIRUS; PHYSIOLOGY; VIROLOGY; ANTIVIRAL THERAPY; POINT MUTATION; POLYMERASE CHAIN REACTION; DRUG EFFECT; HERPES VIRUS INFECTION; INFLUENZA; PROTEIN BINDING; PROTEIN-PROTEIN INTERACTION;

ANIMALS; ANTIVIRAL AGENTS; DNA-DIRECTED RNA POLYMERASES; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; PROTEIN BINDING; PROTEIN SUBUNITS; VIRAL PROTEINS;

ANTIVIRAL THERAPY; HERPESVIRUS; INFLUENZA VIRUS; PROTEIN-PROTEIN INTERACTION; VIRAL POLYMERASE;

EID: 84884562233     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.05.014     Document Type: Review

References (93)

1. Agulnick A.D., Thompson J.R., Iyengar S., Pearson G., Ablashi D., Ricciardi R.P. Identification of a DNA-binding protein of human herpesvirus 6, a putative DNA polymerase stimulatory factor. J. Gen. Virol. 1993, 74(Pt 6):1003-1009.
2. Alvisi G., Jans D.A., Ripalti A. Human cytomegalovirus (HCMV) DNA polymerase processivity factor ppUL44 dimerizes in the cytosol before translocation to the nucleus. Biochemistry (Mosc.) 2006, 45:6866-6872.
3. Alvisi G., Marin O., Pari G., Mancini M., Avanzi S., Loregian A., Jans D.A., Ripalti A. Multiple phosphorylation sites at the C-terminus regulate nuclear import of HCMV DNA polymerase processivity factor ppUL44. Virology 2011, 417:259-267.
4. Appleton B.A., Loregian A., Filman D.J., Coen D.M., Hogle J.M. The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol. Cell 2004, 15:233-244.
5. Appleton B.A., Brooks J., Loregian A., Filman D.J., Coen D.M., Hogle J.M. Crystal structure of the cytomegalovirus DNA polymerase subunit UL44 in complex with the C terminus from the catalytic subunit: differences in structure and function relative to unliganded UL44. J. Biol. Chem. 2006, 281:5224-5232.
6. Baltz J.L., Filman D.J., Ciustea M., Silverman J.E., Lautenschlager C.L., Coen D.M., Ricciardi R.P., Hogle J.M. The crystal structure of PF-8, the DNA polymerase accessory subunit from Kaposi's sarcoma-associated herpesvirus. J. Virol. 2009, 83:12215-12228.
7. Berthomme H., Monahan S.J., Parris D.S., Jacquemont B., Epstein A.L. Cloning, sequencing, and functional characterization of the two subunits of the pseudorabies virus DNA polymerase holoenzyme: evidence for specificity of interaction. J. Virol. 1995, 69:2811-2818.
8. Biswas S.K., Nayak D.P. Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1. J. Virol. 1994, 68:1819-1826.
9. Bridges K.G., Hua Q., Brigham-Burke M.R., Martin J.D., Hensley P., Dahl C.E., Digard P., Weiss M.A., Coen D.M. Secondary structure and structure-activity relationships of peptides corresponding to the subunit interface of herpes simplex virus DNA polymerase. J. Biol. Chem. 2000, 275:472-478.
10. Bridges K.G., Chow C.S., Coen D.M. Identification of crucial hydrogen-bonding residues for the interaction of herpes simplex virus DNA polymerase subunits via peptide display, mutational, and calorimetric approaches. J. Virol. 2001, 75:4990-4998.
11. Bruning J.B., Shamoo Y. Structural and thermodynamic analysis of human PCNA with peptides derived from DNA polymerase-delta p66 subunit and flap endonuclease-1. Structure 2004, 12:2209-2219.
12. Chan S.R., Chandran B. Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains. J. Virol. 2000, 74:10920-10929.
13. Chase G., Wunderlich K., Reuther P., Schwemmle M. Identification of influenza virus inhibitors which disrupt of viral polymerase protein-protein interactions. Methods 2011, 55:188-191.
14. Chen X., Lin K., Ricciardi R.P. Human Kaposi's sarcoma herpesvirus processivity factor-8 functions as a dimer in DNA synthesis. J. Biol. Chem. 2004, 279:28375-28386.
15. Coen D.M. Viral DNA polymerases. DNA Replication in Eukaryotic Cells 1996, 495-523. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
16. Davison A.J., Scott J.E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 1986, 67(Pt 9):1759-1816.
17. De Clercq E. Antiviral agents active against influenza A viruses. Nat. Rev. Drug. Discov. 2006, 5:1015-1025.
18. Dias A., Bouvier D., Crepin T., McCarthy A.A., Hart D.J., Baudin F., Cusack S., Ruigrok R.W. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 2009, 458:914-918.
19. Digard P., Coen D.M. A novel functional domain of an alpha-like DNA polymerase. The binding site on the herpes simplex virus polymerase for the viral UL42 protein. J. Biol. Chem. 1990, 265:17393-17396.
20. Digard P., Blok V.C., Inglis S.C. Complex formation between influenza virus polymerase proteins expressed in Xenopus oocytes. Virology 1989, 171:162-169.
21. Digard P., Bebrin W.R., Weisshart K., Coen D.M. The extreme C terminus of herpes simplex virus DNA polymerase is crucial for functional interaction with processivity factor UL42 and for viral replication. J. Virol. 1993, 67:398-406.
22. Digard P., Chow C.S., Pirrit L., Coen D.M. Functional analysis of the herpes simplex virus UL42 protein. J. Virol. 1993, 67:1159-1168.
23. Digard P., Williams K.P., Hensley P., Brooks I.S., Dahl C.E., Coen D.M. Specific inhibition of herpes simplex virus DNA polymerase by helical peptides corresponding to the subunit interface. Proc. Natl. Acad. Sci. USA 1995, 92:1456-1460.
24. Dorjsuren D., Burnette A., Gray G.N., Chen X., Zhu W., Roberts P.E., Currens M.J., Shoemaker R.H., Ricciardi R.P., Sei S. Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis. Antiviral Res. 2006, 69:9-23.
25. Ertl P.F., Powell K.L. Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells. J. Virol. 1992, 66:4126-4133.
26. Fukuoka M., Minakuchi M., Kawaguchi A., Nagata K., Kamatari Y.O., Kuwata K. Structure-based discovery of anti-influenza virus A compounds among medicines. Biochim. Biophys. Acta 2012, 1820:90-95.
27. Gallo M.L., Dorsky D.I., Crumpacker C.S., Parris D.S. The essential 65-kilodalton DNA-binding protein of herpes simplex virus stimulates the virus-encoded DNA polymerase. J. Virol. 1989, 63:5023-5029.
28. Ganem D. KSHV and Kaposi's sarcoma: the end of the beginning?. Cell 1997, 91:157-160.
29. Gao Y., Colletti K., Pari G.S. Identification of human cytomegalovirus UL84 virus- and cell-encoded binding partners by using proteomics analysis. J. Virol. 2008, 82:96-104.
30. Garner A.L., Janda K.D. Protein-protein interactions and cancer: targeting the central dogma. Curr. Top. Med. Chem. 2011, 11:258-280.
31. Ghanem A., Mayer D., Chase G., Tegge W., Frank R., Kochs G., Garcia-Sastre A., Schwemmle M. Peptide-mediated interference with influenza A virus polymerase. J. Virol. 2007, 81:7801-7804.
32. Gonzalez S., Zurcher T., Ortin J. Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res. 1996, 24:4456-4463.
33. Gottlieb J., Marcy A.I., Coen D.M., Challberg M.D. The herpes simplex virus type 1 UL42 gene product: a subunit of DNA polymerase that functions to increase processivity. J. Virol. 1990, 64:5976-5987.
34. Guilligay D., Tarendeau F., Resa-Infante P., Coloma R., Crepin T., Sehr P., Lewis J., Ruigrok R.W., Ortin J., Hart D.J., Cusack S. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat. Struct. Mol. Biol. 2008, 15:500-506.
35. Gulbis J.M., Kelman Z., Hurwitz J., O'Donnell M., Kuriyan J. Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA. Cell 1996, 87:297-306.
36. Hamatake R.K., Bifano M., Tenney D.J., Hurlburt W.W., Cordingley M.G. The herpes simplex virus type 1 DNA polymerase accessory protein, UL42, contains a functional protease-resistant domain. J. Gen. Virol. 1993, 74(Pt 10):2181-2189.
37. He X., Zhou J., Bartlam M., Zhang R., Ma J., Lou Z., Li X., Li J., Joachimiak A., Zeng Z., Ge R., Rao Z., Liu Y. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus. Nature 2008, 454:1123-1126.
38. Kedes D.H., Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J. Clin. Invest. 1997, 99:2082-2086.
39. Kim Y.E., Ahn J.H. Role of the specific interaction of UL112-113 p84 with UL44 DNA polymerase processivity factor in promoting DNA replication of human cytomegalovirus. J. Virol. 2010, 84:8409-8421.
40. Krosky P.M., Baek M.C., Jahng W.J., Barrera I., Harvey R.J., Biron K.K., Coen D.M., Sethna P.B. The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J. Virol. 2003, 77:7720-7727.
41. Li C., Ba Q., Wu A., Zhang H., Deng T., Jiang T. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral. Polymerase assembly. FEBS J. 2013, 280:1139-1149.
42. Lin K., Dai C.Y., Ricciardi R.P. Cloning and functional analysis of Kaposi's sarcoma-associated herpesvirus DNA polymerase and its processivity factor. J. Virol. 1998, 72:6228-6232.
43. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev. 2001, 46:3-26.
44. Liu H., Yao X. Molecular basis of the interaction for an essential subunit PA-PB1 in influenza virus RNA polymerase: insights from molecular dynamics simulation and free energy calculation. Mol. Pharm. 2010, 7:75-85.
45. Loregian A., Coen D.M. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase. Chem. Biol. 2006, 13:191-200.
46. Loregian A., Palù G. Disruption of protein-protein interactions: towards new targets for chemotherapy. J. Cell. Physiol. 2005, 204:750-762.
47. Loregian A., Palù G. Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy. Clin. Microbiol. Infect. 2005, 11:437-446.
48. Loregian A., Papini E., Satin B., Marsden H.S., Hirst T.R., Palù G. Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc. Natl. Acad. Sci. USA 1999, 96:5221-5226.
49. Loregian A., Piaia E., Cancellotti E., Papini E., Marsden H.S., Palù G. The catalytic subunit of herpes simplex virus type 1 DNA polymerase contains a nuclear localization signal in the UL42-binding region. Virology 2000, 273:139-148.
50. Loregian A., Marsden H.S., Palù G. Protein-protein interactions as targets for antiviral chemotherapy. Rev. Med. Virol. 2002, 12:239-262.
51. Loregian A., Rigatti R., Murphy M., Schievano E., Palù G., Marsden H.S. Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit. J. Virol. 2003, 77:8336-8344.
52. Loregian A., Appleton B.A., Hogle J.M., Coen D.M. Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44. J. Virol. 2004, 78:158-167.
53. Loregian A., Appleton B.A., Hogle J.M., Coen D.M. Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit. J. Virol. 2004, 78:9084-9092.
54. Loregian A., Sinigalia E., Mercorelli B., Palù G., Coen D.M. Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism. Nucleic Acids Res. 2007, 35:4779-4791.
55. Marschall M., Freitag M., Suchy P., Romaker D., Kupfer R., Hanke M., Stamminger T. The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology 2003, 311:60-71.
56. Marsden H.S., Murphy M., McVey G.L., MacEachran K.A., Owsianka A.M., Stow N.D. Role of the carboxy terminus of herpes simplex virus type 1 DNA polymerase in its interaction with UL42. J. Gen. Virol. 1994, 75(Pt 11):3127-3135.
57. Medveczky M.M., Horvath E., Lund T., Medveczky P.G. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 1997, 11:1327-1332.
58. Mercorelli B., Sinigalia E., Loregian A., Palù G. Human cytomegalovirus DNA replication: antiviral targets and drugs. Rev. Med. Virol. 2008, 18:177-210.
59. Muratore G., Goracci L., Mercorelli B., Foeglein A., Digard P., Cruciani G., Palù G., Loregian A. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. Proc. Natl. Acad. Sci. USA 2012, 109:6247-6252.
60. Muratore G., Mercorelli B., Goracci L., Cruciani G., Digard P., Palù G., Loregian A. Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses. Antimicrob. Agents Chemother. 2012, 56:6009-6013.
61. Murayama K., Nakayama S., Kato-Murayama M., Akasaka R., Ohbayashi N., Kamewari-Hayami Y., Terada T., Shirouzu M., Tsurumi T., Yokoyama S. Crystal structure of Epstein-Barr virus DNA polymerase processivity factor BMRF1. J. Biol. Chem. 2009, 284:35896-35905.
62. Obayashi E., Yoshida H., Kawai F., Shibayama N., Kawaguchi A., Nagata K., Tame J.R., Park S.Y. The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature 2008, 454:1127-1131.
63. Ohtsu Y., Honda Y., Sakata Y., Kato H., Toyoda T. Fine mapping of the subunit binding sites of influenza virus RNA polymerase. Microbiol. Immunol. 2002, 46:167-175.
64. Palese P., Shaw M.L. Orthomyxoviridae: the viruses and their replication. Fields' Virology 2007, 1648-1698. Lippincott Williams & Wilkins, Philadelphia. 5th ed.
65. Pari G.S., Anders D.G. Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J. Virol. 1993, 67:6979-6988.
66. Pari G.S., Kacica M.A., Anders D.G. Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis. J. Virol. 1993, 67:2575-2582.
67. Perez D.R., Donis R.O. A 48-amino-acid region of influenza A virus PB1 protein is sufficient for complex formation with PA. J. Virol. 1995, 69:6932-6939.
68. Perez D.R., Donis R.O. Functional analysis of PA binding by influenza a virus PB1: effects on polymerase activity and viral infectivity. J. Virol. 2001, 75:8127-8136.
69. Pilger B.D., Cui C., Coen D.M. Identification of a small molecule that inhibits herpes simplex virus DNA polymerase subunit interactions and viral replication. Chem. Biol. 2004, 11:647-654.
70. Poole E.L., Medcalf L., Elton D., Digard P. Evidence that the C-terminal PB2-binding region of the influenza A virus PB1 protein is a discrete alpha-helical domain. FEBS Lett. 2007, 581:5300-5306.
71. Prichard M.N., Lawlor H., Duke G.M., Mo C., Wang Z., Dixon M., Kemble G., Kern E.R. Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA. J. Virol. 2005, 2:55.
72. Ranneberg-Nilsen T., Dale H.A., Luna L., Slettebakk R., Sundheim O., Rollag H., Bjoras M. Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44). J. Mol. Biol. 2008, 381:276-288.
73. Reuther P., Manz B., Brunotte L., Schwemmle M., Wunderlich K. Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences. J. Virol. 2011, 85:13298-13309.
74. Ripalti A., Boccuni M.C., Campanini F., Landini M.P. Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J. Virol. 1995, 69:2047-2057.
75. Sakurai S., Kitano K., Yamaguchi H., Hamada K., Okada K., Fukuda K., Uchida M., Ohtsuka E., Morioka H., Hakoshima T. Structural basis for recruitment of human flap endonuclease 1 to PCNA. EMBO J. 2005, 24:683-693.
76. Silva L.A., Loregian A., Pari G.S., Strang B.L., Coen D.M. The carboxy-terminal segment of the human cytomegalovirus DNA polymerase accessory subunit UL44 is crucial for viral replication. J. Virol. 2010, 84:11563-11568.
77. Silva L.A., Strang B.L., Lin E.W., Kamil J.P., Coen D.M. Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44. Virology 2011, 417:268-280.
78. Sinigalia E., Alvisi G., Mercorelli B., Coen D.M., Pari G.S., Jans D.A., Ripalti A., Palù G., Loregian A. Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells. J. Virol. 2008, 82:12574-12579.
79. Sinigalia E., Alvisi G., Segre C.V., Mercorelli B., Muratore G., Winkler M., Hsiao H.H., Urlaub H., Ripalti A., Chiocca S., Palù G., Loregian A. The human cytomegalovirus DNA polymerase processivity factor UL44 Is modified by SUMO in a DNA-dependent manner. PLoS One 2012, 7:e49630.
80. Stow N.D. Sequences at the C-terminus of the herpes simplex virus type 1 UL30 protein are dispensable for DNA polymerase activity but not for viral origin-dependent DNA replication. Nucleic Acids Res. 1993, 21:87-92.
81. Strang B.L., Sinigalia E., Silva L.A., Coen D.M., Loregian A. Analysis of the association of the human cytomegalovirus DNA polymerase subunit UL44 with the viral DNA replication factor UL84. J. Virol. 2009, 83:7581-7589.
82. Strang B.L., Boulant S., Coen D.M. Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication. J. Virol. 2010, 84:1771-1784.
83. Strang B.L., Geballe A.P., Coen D.M. Association of human cytomegalovirus proteins IRS1 and TRS1 with the viral DNA polymerase accessory subunit UL44. J. Gen. Virol. 2010, 91:2167-2175.
84. Sugiyama K., Obayashi E., Kawaguchi A., Suzuki Y., Tame J.R., Nagata K., Park S.Y. Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase. EMBO J. 2009, 28:1803-1811.
85. Tenney D.J., Micheletti P.A., Stevens J.T., Hamatake R.K., Matthews J.T., Sanchez A.R., Hurlburt W.W., Bifano M., Cordingley M.G. Mutations in the C terminus of herpes simplex virus type 1 DNA polymerase can affect binding and stimulation by its accessory protein UL42 without affecting basal polymerase activity. J. Virol. 1993, 67:543-547.
86. Torreira E., Schoehn G., Fernandez Y., Jorba N., Ruigrok R.W., Cusack S., Ortin J., Llorca O. Three-dimensional model for the isolated recombinant influenza virus polymerase heterotrimer. Nucleic Acids Res. 2007, 35:3774-3783.
87. Valkov E., Sharpe T., Marsh M., Greive S., Hyvonen M. Targeting protein-protein interactions and fragment-based drug discovery. Top. Curr. Chem. 2012, 317:145-179.
88. Wells J.A., McClendon C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007, 450:1001-1009.
89. Wunderlich K., Mayer D., Ranadheera C., Holler A.S., Manz B., Martin A., Chase G., Tegge W., Frank R., Kessler U., Schwemmle M. Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. PLoS One 2009, 4:e7517.
90. Yuan P., Bartlam M., Lou Z., Chen S., Zhou J., He X., Lv Z., Ge R., Li X., Deng T., Fodor E., Rao Z., Liu Y. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 2009, 458:909-913.
91. Zhang Q., Hong Y., Dorsky D., Holley-Guthrie E., Zalani S., Elshiekh N.A., Kiehl A., Le T., Kenney S. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: effects on EBV transcription and lytic replication. J. Virol. 1996, 70:5131-5142.
92. Zhou X., Liao Q., Ricciardi R.P., Peng C., Chen X. Kaposi's sarcoma-associated herpesvirus processivity factor-8 dimerizes in cytoplasm before being translocated to nucleus. Biochem. Biophys. Res. Commun. 2010, 397:520-525.
93. Zuccola H.J., Filman D.J., Coen D.M., Hogle J.M. The crystal structure of an unusual processivity factor, herpes simplex virus UL42, bound to the C terminus of its cognate polymerase. Mol. Cell 2000, 5:267-278.